EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enkephalin Treatment Reduces Elevated Brain Glia in Mice With Experimental Autoimmune Encephalomyelitis

Rashmi Kumari, Ian S Zagon, Patricia J McLaughlin

Journal of Integrative Neuroscience · 13.10.2026 · 25 (10)

DOI: 10.31083/jin52956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 13.10.2026. Verfasst von Rashmi Kumari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, PA 17033, USA. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Enkephalin, Methionine, Naltrexone, Narcotic Antagonists. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Paul K. and Anna E. Shockey Family Foundation, Penn State LDN Now fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple sclerosis (MS) is a chronic, autoimmune disorder that culminates in severe motor and cognitive deficits. The progression of the disease is associated with inflammation and demyelination of the brain and spinal cord. Activation and proliferation of glia, including astrocytes and oligodendrocytes, in the brain are hallmarks. Persons with MS (PwMS) have significantly low levels of the neuropeptide [Met5]-enkephalin (Met5-Enk), also termed Opioid Growth Factor (OGF) that is an inhibitory growth factor and modulates cellular homeostasis. Treatment with low doses of naltrexone, an opioid antagonist that blocks the receptor OGFr, is reported to decrease inflammation, neutralize pro-inflammatory cytokine secretion, and stabilize disease progression. Intermittent blockade of OGFr with low doses of naltrexone stimulates serum enkephalin levels. In this investigation, brains of mice with experimental autoimmune encephalomyelitis (EAE) were treated with low dose naltrexone (LDN) or OGF/Met-Enk and examined for reactive astrocytes and oligodendrocytes.

Methods

Female C57BL/6J mice were inoculated with myelin oligodendrocyte glycoprotein (MOG35–55) to induce EAE. At the initial appearance of clinical behavioral symptoms, mice were randomized to receive 10 mg/kg [Met5]-enkephalin (OGF/Met-Enk), 0.1 mg/kg naltrexone (LDN), or 0.1 mL phosphate-buffered saline (PBS) daily. At 35 days post EAE induction, mice were euthanized, and the brains were removed and prepared for immunohistochemistry. The corpus callosum, subventricular zone, and dentate gyrus were stained with glial fibrillary acidic protein (GFAP) and adenomatous polyposis coli protein (APC) antibodies to detect astrocytes and oligodendrocytes, respectively.

Results

The number of reactive astroglia in EAE brains was elevated relative to the number in normal mouse brains. Daily treatment with OGF/Met-Enk reduced GFAP-positive cells in all 3 brain regions, and LDN reduced astrocyte number in the corpus callosum and subventricular zone. Astrocytes in treated EAE mice had process lengths that were comparable with those in normal mice, suggesting less reactivity. The numbers of oligodendrocytes in the corpus callosum of EAE+LDN mice were significantly reduced relative to EAE+PBS tissues.

Conclusions

These results demonstrate quantitative changes in reactive glia in EAE mouse brains following treatment with OGF/Met-Enk and LDN and corroborate other studies showing that OGF/Met-Enk and LDN treatment increase plasma enkephalins, reduce inflammation and decrease pro-inflammatory cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalEnkephalin, MethionineNaltrexoneNarcotic AntagonistsBrainAstrocytesNeurogliaAnimalsFemaleMiceMice, Inbred C57BL

Stichwörter der Autor:innen

[Met5]-enkephalinastrocytescorpus callosumdentate gyrusoligodendrocytessubventricular zone

Substanzen

Enkephalin, MethionineNaltrexoneNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, PA 17033, USA.

Förderung

  • Paul K. and Anna E. Shockey Family Foundation
  • Penn State LDN Now fund

Zitieren

APA

Kumari, R., Zagon, I. S., & McLaughlin, P. J. (2026). Enkephalin Treatment Reduces Elevated Brain Glia in Mice With Experimental Autoimmune Encephalomyelitis. Journal of Integrative Neuroscience, 25(10). https://doi.org/10.31083/jin52956

Vancouver

Kumari R, Zagon IS, McLaughlin PJ. Enkephalin Treatment Reduces Elevated Brain Glia in Mice With Experimental Autoimmune Encephalomyelitis. Journal of Integrative Neuroscience. 2026;25(10). doi:10.31083/jin52956

BibTeX
@article{Kumari2026,
  author = {Kumari, Rashmi and Zagon, Ian S and McLaughlin, Patricia J},
  title = {Enkephalin Treatment Reduces Elevated Brain Glia in Mice With Experimental Autoimmune Encephalomyelitis},
  journal = {Journal of Integrative Neuroscience},
  year = {2026},
  volume = {25},
  number = {10},
  doi = {10.31083/jin52956}
}
Kostenlos starten →